Marketresearchnews

Tuesday, 23 October 2018

EMEA Hospital Bed Market, Trends, Absolute Opportunity and Value Chain 2018

Market Synopsis of Hospital bed Market:

Market Scenario:

Beds are the primary requirements for the healthcare facilities providers. The prime objective of these care centers are to provide comfort and relief to the patients. When patient arrives in the hospital he is unable to move. The beds available for the purpose of healthcare are specially designed for the comfort of the patients.

Beds used in the healthcare facility centers are customized or specially modified beds. The modifications are made to for convenience of the patients. The modifications are made for the purpose of adding features to the beds. The features include adjustable heights, adjustable size, and also for the sections like head and feet. The features also include wheels, automations button for the electric devices and side trail rails and many more.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/613

Patients with conditions like cardiac problems, cancer, renal problems, bone fractures, spine fracture, pregnant women, old aged people and children are the major utilizers of hospitals beds. Patients are made comfortable in hospitals with the different features of beds. As the beds are available with all features required by the patient conditions. The only matter of concern is of price of the beds. But the governments and the private companies do spend much on the healthcare expenditures that helps the user to utilize the facilities.

The Europe, Middle East & Africa market of hospital beds is steady growing because of the Europe has increasing expenditures on the advanced technology in healthcare. Growing number of chronic diseases, non-chronic diseases is also rising. The market of Middle East & Africa is growing at a steady pace, but the government of this regions are providing schemes and consolidations for the healthcare facilities. Also in the Middle East and Africa region the number of incidence of the chronic diseases are increasing. The requirement for the beds and the demand from the healthcare centers is high. The overall Europe, Middle East & Africa market of hospital beds is expected to grow with a CAGR of 4%.

Study Objectives of Europe, Middle East & Africa Hospital Bed Market:

To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the Hospital bed market
To provide insights about factors influencing the market growth
To analyze the hospital bed market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
To provide historical and forecast revenue of the market segments and sub-segments with respect to countries of Europe, Middle East & Africa.
To provide country level analysis of the market with respect to the current market size and future prospective
To provide country level analysis of the market for segments by hospital bed type, by application type and by end users and its sub-segments.
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Europe, Middle East & Africa hospital bed market.

Key Players for Hospital bed Market:

Some of the Key Players in This Market Are: Stryker Corporation, Hilli Rom Holding. Inc., Getinge Group, Paramount Bed Co. Ltd., Invacare Corporation, Arjo Hunjtleigh, and others

Segments:

Europe, Middle East & Africa hospital bed market has been segmented on the basis of types which comprises type (Standard bed, Manual bed, Hydraulic bed and Electric bed), application types (Medical/Surgical bed, Critical care bed, Maternity bed, Bariatric bed and others) and the end users types (Hospitals & Clinics, Nursing homes and Maternity homes).
Read Comprehensive Overview of Report @ https://www.marketresearchfuture.com/reports/europe-hospital-bed-market-613Regional Analysis of hospital bed Market:

Europe, Middle East & Africa region is steady growing market for the hospital bed. The Europe market for hospital bed is expected to grow at a CAGR of 4% during the forecasted period. The Europe market value was estimated USD 1,650 million in 2015 and is expected to reach USD 2,100 million by 2023. This is due to increasing expenditures on advanced technology for healthcare and increasing number of chronic and non-chronic diseases. Where the market for the Middle East & Africa is expected to grow at a rate of 2.5% CAGR during the forecasted period. The market in Middle East and Africa are rising due to the government schemes and consolidation schemes for the people. The market for Middle East & Africa is less than the developed countries.

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Patellar Tendinitis Market 2018 Market Challenge, Driver, Trends & Forecast to 2023

Market Scenario

Tendons are thick cords that attach the muscles to the bones. Inflammation of these tendons is known as tendinitis. Repetitive movement, injury or diseases conditions are main causes of the tendinitis, with severe pain, swelling or tenderness at the affected area. Use of over-the-counter drugs or pain relievers such as non-steroidal anti-inflammatory drugs (NSAIDs), rest therapy and physical therapy are commonly used treatment measures for this condition. Delayed diagnosis of patellar tendinitis may require a surgery to reduce pain, and improve the movement. Tendinitis is found to be prevalent among athletes or sports players as a result of continuous strain on the tendons due to a rigorous workout, running and other activities. Moreover, patellar tendinitis is an injury to the tendon connecting kneecap (patella). The patellar tendon works with the muscles at the front of the thigh to knee. Patellar tendinitis or tendonitis is also known as jumper's knee and is most common in athletes whose sports involve frequent jumping such as basketball and volleyball. However, even people who don't participate in jumping sports can get patellar tendinitis

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5134

Increasing prevalence of sports injury, increasing investment by biotechnology and pharmaceutical industries in R&D, and rising need for the better treatment methods drive the growth of the market. Furthermore, favorable reimbursement policies, increased application and significant investments in the development of new technologies for the treatment of diseases are likely to fuel the market growth during the forecast period. Moreover, increasing geriatric population is boost the market growth. Established market players in the developed countries lead the globalization by pushing new products and services into the developing countries and emerging economies. However, side-effects and higher treatment cost may hinder the market growth during the forecast period.

The global patellar tendinitis market is expected to grow at a CAGR of ~8.1% during the forecast period 2017-2023.

Intended Audience

Pharmaceutical and Biotechnological Companies
Research and Development (R&D) Companies
Ambulatory Care Centers
Academic Institutes and Universities
Market Research and Consulting Service Providers
Potential Investors

Segmentations

The global patellar tendinitis market is segmented on the basis of diagnosis, treatment, and end user.

On the basis of the diagnosis, it is segmented into the physical examination, imaging tests, and others. The imaging test is further segmented into X-rays, Ultrasound, and Magnetic resonance imaging (MRI).

The treatment segment is divided into corticosteroid injection, platelet-rich plasma injection, surgery, Medical devices, and others. The medical devices are further segmented into the mechanical band, support tape, pre-cut strips, continuous rolls, and others.

Based on the end user, it is segmented into hospitals & clinics, research laboratories, and others.

Regional Analysis

The Americas dominate the global patellar tendinitis market owing to well-developed technology, increasing patient population for sports injury, high health care spending, and increasing government support for research & development. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the market in this region.

Europe holds the second position in the global patellar tendinitis market owing to the government support for research & development and availability of funds for research. This is expected to continue to drive the European market over the forecasted period. For instance, developed economies such as Germany and France are increasing investment in the healthcare domain and are focusing more on hospital infrastructure.

The Asia Pacific is the fastest growing patellar tendinitis market owing to the presence of rapidly developing healthcare technology and high healthcare expenditure. Moreover, increasing patient population in countries like India and South Korea are likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare sector is projected to lead the use of advanced equipment, which, in turn, may increase the market growth in this region.

Read Comprehensive Overview of Report @ https://www.marketresearchfuture.com/reports/patellar-tendinitis-market-5134

On the other hand, the Middle East & Africa holds the least share of the market owing to less availability of funds, limited medical facilities, and deprived political conditions in Africa.

Key Players

Some of key the players in the market are Abbott (U.S.), Pfizer (U.S.), AstraZeneca (U.K), Bayer (Germany), Merck & Co. Inc. (Germany), GlaxoSmithKline plc (U.S.), Teva Pharmaceutical Industries (Israel), Boehringer Ingelheim Pharmaceuticals, Inc. (Germany), and others.

Male Breast Cancer Market - Overall Industry Analysis By Types, By Therapy and By End Users during forecast period 2017-2023

Market Scenario

The global male breast cancer market is expected to grow slowly at a CAGR of ~ 3.6% during the forecast period from 2018 to 2023. Male breast cancer is caused when the breast tissues of males start growing out of control and become cancerous.

Numerous factors such as increasing obese population and growing geriatric population are expected to drive the growth of the market. For instance, in July 2017, the Bristol-Myers Squibb Company announced a broad clinical collaboration with Clovis Oncology for evaluating the combination of cancer drugs Nivolumab and Rucaparib in Phase 2 and Phase 3 clinical trials in multiple tumor types.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/6505

Moreover, favorable healthcare expenditures boost the growth of the market. However, lack of knowledge and the high cost of treatments may hamper the market growth during the assessment period.

Segmentation

The global male breast cancer market has been segmented into type, diagnosis, and treatment.
The market, on the basis of type, has been segmented into, ductal carcinoma in situ, Paget’s disease of the nipple, inflammatory breast cancer, and infiltrating ductal carcinoma.

The market, by diagnosis, has been segmented into, mammography, biopsy, PET scan, CT scan, MRI scan, and other tests. On the basis of diagnosis, biopsy is anticipated to record the largest growth owing to its accuracy of diagnosing the disease. It is also expected to be the fastest growing segment.

By diagnosis, biopsy is further segmented into, fine needle aspiration biopsy, core biopsy, and excisional biopsy.
The market, by treatment, has been segmented into, local treatments and systemic treatments.
By treatment, local treatments are further segment into, surgery and radiation therapy.
Surgery is further segmented into, mastectomy, breast-conserving surgery, and lymph nodes biopsy.
By treatment, systemic treatments are further segmented into, chemotherapy, hormone therapy, and targeted therapy.
Chemotherapy is further segmented into, adjuvant therapy and neoadjuvant therapy.
Hormone therapy is further segmented into, using drugs and orchiectomy (castration).
Targeted therapy is further segmented into, for HER2 positive breast cancer, for hormone receptor-positive breast cancer, and for cancer with BRCA mutations.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The male breast cancer market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European male breast cancer market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The male breast cancer market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The male breast cancer market in the Middle East and Africa has been segmented into the Middle East and Africa.
Key players
Achieve Life Sciences, Inc., Pfizer, Eli Lilly and Company, Bristol-Myers Squibb Company, F. Hoffmann-La Roche, Sanofi, Novartis AG, BioNumerik Pharmaceuticals Inc., Seattle Genetics, Inc., GlaxoSmithKline plc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., AstraZeneca, Accord Healthcare, and Bayer AG are some of the key players in the global male breast cancer market.

Regional Market Summary

Global Male Breast Cancer Market Share (%), by Region, 2017

Source: World Health Organization (WHO), Centers for Disease Control and Prevention (CDC)

Geographically, the Americas is anticipated to dominate the global male breast cancer market owing to the changing lifestyle and rising prevalence of breast cancer. According to an article published by, the American Cancer Society in April 2018, the lifetime risk of getting breast cancer in men is approximately 1 in 833. Europe is expected to hold the second largest position in the global male breast cancer market. The market growth in this region is attributed to the growing prevalence of rare cancers, the availability of funds for research, and increasing healthcare expenditure. According to the Cancer Research UK, 371 new cases of male breast cancer were reported in 2015 in the UK.

Read Comprehensive Overview of Report @ https://www.marketresearchfuture.com/reports/male-breast-cancer-market-6505

Asia-Pacific is anticipated to be the fastest growing region in the market due to the rising awareness regarding early symptoms of cancer and government support for healthcare facilities. According to a study published by the European Society for Medical Oncology in January 2016, there were 4.3 million new cases of cancer in China in 2015.

On the other hand, the Middle East and Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle Eastern region due to growing government initiatives for the healthcare sector.

Monday, 22 October 2018

Magnetic Resonance Imaging (MRI) Market Trends, Analysis and Review during 2018 To 2023

The global Magnetic Resonance Imaging (MRI) Systems market is expected to be of value USD 5 Billion in 2023 and to grow at a depict 3.5% CAGR during the forecast period. Magnetic resonance imaging (MRI) systems is a non-invasive technique in which light is used to interrogate cellular and molecular function in the living body by exploiting the special properties of photons. Magnetic resonance imaging (MRI) systems are surpassing the radiology imaging market due to its myriad advantages over it. This market is mainly driven by rising demand for non-invasive procedures, harmful effects of radiation-based imaging, increase in research and development activities in the life sciences sector, and increasing application of magnetic resonance imaging (MRI) systems techniques in drug discovery processes and preclinical research, Moreover factors such as rising geriatric population which leads to increase in cardiovascular, neurological and ophthalmic disorders is also fueling the growth of this market. However, the market growth is restricted by factors such as stringent regulatory approval procedures high costs of instruments, scarcity of skilled operators, and insufficient reimbursements policies for magnetic resonance imaging (MRI) systems procedures.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/6194

Market Segmentation

The global magnetic resonance imaging (MRI) systems market is segmented on the basis of type, field strength, disease application and end user.

Considering the type, the market is segmented into open MRI, closed MRI, standard bore MRI, wide-bore MRI.

On the basis of field strength, the market is segmented into high-field MRI systems, 1.5t MRI systems, 3t MRI systems, low-to-mid-field MRI systems, very-high-field MRI systems, and others.

On account of disease application, the market is segmented into the spine and musculoskeletal MRI, brain and neurological MRI, pelvic and abdominal MRI, breast MRI, cardiovascular MRI, and others

According to the end user, the market is segmented into diagnostic imaging centers, hospitals and clinics, research laboratories, and pharmaceutical &biotechnology companies.

Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. The American region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe.

Market Players

Hitachi
Siemens AG
Canon Medical Systems
GE Healthcare
Philips
Toshiba Corporation
Toshiba Corporation
Xingaoyi
Aurora Imaging Technologies, Inc.

Regional Market Summary

In terms of geography, Americas dominates the market for Magnetic Resonance Imaging (MRI) systems owing to increasing prevalence of cardiovascular, neurological and ophthalmic disorders pertaining to rising geriatric population which is a major trigger factor for this disease. Additionally, factors such as increasing government initiatives and funding for research in the medical devices sector, rising demand for accurate diagnosis, awareness about adverse effects of radiation imaging, ability to provide in-depth images of soft tissues and vascular systems, and the presence of pharmaceutical giants also propel the market growth in this region. For instance, according to National Center for Health Statistics report in 2016, around 140,323 mortality occurred due to cerebrovascular disease or stroke in the US Thus, this rising patient pool is going to boost up the market growth during the forecast period.

Europe accounts for the second largest market and holds a healthy share in the global magnetic resonance Imaging (MRI) systems market due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure, good healthcare infrastructure and flourishing medical device industry due to the presence of major market players. Additionally, knowledge about the benefits of Magnetic Resonance Imaging (MRI) Systems over radiation imaging and capability of inhabitants to afford the diagnostics is spurring the market growth.

Asia Pacific is expected to be the fastest growing market with most promising growth possibilities. According to a report published by the Department of Neurology in 2014, it is estimated that for the current population of 1.27 billion, approximately 30 million people suffer from neurological disorders in India. Thus, owing to the huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, availability favorable insurance policies market growth will be accelerated during the forecast period. Moreover, due to lower cost of clinical trials and research key players have been setting up their regional headquarters and manufacturing plants in Singapore, China, Japan, Korea, and Australia which make a positive growth curve in Magnetic Resonance Imaging (MRI) Systems market in future.

The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates and Saudi Arabia is the largest market share owing to the development of healthcare industry and rising availability of specialty care centers. Hence, the market might show steady growth due to Saudi Arabia, the UAE market growth, and government initiatives to improve quality of healthcare in the Africa region.

Read Comprehensive Overview of Report @ https://www.marketresearchfuture.com/reports/magnetic-resonance-imaging-market-6194

Cardiopulmonary Disease Diagnostics and Treatment Market Analysis 2018 (By Segment, Key Players and Applications) and Forecasts To 2023

Market Scenario

The cardiopulmonary disease is used to describe a wide range of series of disorders which affect the heart and the lungs. Cardiovascular disease is a universal term for conditions affecting the heart or blood vessels. It's usually related with a build-up of fatty deposits inside the arteries known as atherosclerosis. It can also be related with an injury to arteries in organs such as the brain, kidney, and heart. Respiratory disease is a medical term that includes extreme conditions affecting the organs and tissues which make gas exchange possible in higher organisms. Respiratory diseases range from mild to self-limiting, such as the common cold, to life-threatening entities like bacterial pneumonia, pulmonary embolism, and lung cancer.

Treatment options vary depending on the type of cardiopulmonary disease present and may include changes in diet or lifestyle, use of medications issued on prescription or surgery. The most common cardiopulmonary diseases are hypertension, stroke, and coronary heart disease. Untreated, cardiopulmonary diseases can be deadly. Cardiopulmonary diseases are the major cause of death globally.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/6390

The substantial growth in the frequency of health conditions related to the lungs and heart is the key factor to boosts the growth of this market. Also, the increase in aged population and the rising frequency in cardiovascular and respiratory diseases is also anticipated to drive the global market over the forecast period. Exposure to nicotine, tobacco products, and others increases the risk of obtaining cardiopulmonary diseases.

Increase in the rise of advanced technological equipment’s for diagnosing the disease will drive market rate exponentially. However, the huge cost of treatment and the regulatory nature of government on pharmaceutical companies will hamper the growth of the market.

Segmentation

The global cardiopulmonary disease diagnostics and treatment market has been segmented on the basis of disease type, type, and end-user.

On the basis of disease type, the market has been classified as cardiovascular and respiratory diseases. The cardiovascular diseases are segmented into coronary artery disease, angina pectoris, myocardial infarction, dysrhythmia, hypertension, and others. The respiratory diseases are segmented into influenza, asthma, bronchitis, emphysema, cystic fibrosis, and others.

On the basis of type, the market has been classified as diagnosis and treatment. The diagnosis market is segmented into an electrocardiogram (ECG), Holter monitoring, echocardiogram, stress test, cardiac catheterization, cardiac computerized tomography (CT) scan, cardiac magnetic resonance imaging (MRI), single-photon emission computed tomography (SPECT), stress blood pressure monitors, pulse oximeters and spirometry. The treatment market is segmented into medications. The medications segment is further sub-segmented into angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBS), anticoagulants, antiplatelet agents and others.

On the basis of end users, the market has been classified as hospitals, clinics, diagnostic centers, specialty clinics and rehab centers, research institutes and others.

On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.

The European cardiopulmonary disease diagnostics and treatment market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The cardiopulmonary disease diagnostics and treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The cardiopulmonary disease diagnostics and treatment market in the Middle East and Africa has been segmented into the Middle East and Africa.

In the cardiopulmonary disease diagnostics and treatment market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and due to favorable compensation setting for many surgical procedures.

The European market is expected to hold the second largest market share. The market growth in this region can be attributed to rising frequency of cardiovascular disorders, increasing number of surgeries and increasing demand for advanced treatment procedures are boosting the European market.

The market share in Asia-Pacific is also projected to experience growth in the near future due to access to optimal treatment facilities and growing demand for advanced technology, better adoption rate, increase in disposable income, and rising medical tourism.

The market in the Middle East and Africa is expected to account for the smallest share of the global cardiopulmonary disease diagnostics and treatment market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

Key Players

Some of the key players in the global cardiopulmonary disease diagnostics and treatment market are Cardinal Health, Cosmed Medical, GE Healthcare, Halma plc, Hill-Rom Holdings, Inc., Koninklijke Philips N.V., MGC Diagnostics Corporation, NIHON KOHDEN CORPORATION, Schiller AG, Masimo Corporation, and Vyaire Medical Inc.

Read Comprehensive Overview of Report @ https://www.marketresearchfuture.com/reports/cardiopulmonary-disease-diagnostics-treatment-market-6390

Artificial Neural Network Market Top Trends, Regulations and Competitive Landscape Outlook To 2023

Market Scenario

The global artificial neural network market is expected to grow significantly over the forecast period. It is estimated that the global artificial neural network market is expected to grow significantly during the forecast period from 2018 to 2023.

An artificial neuron network is a computational model which resembles the function and structure of the human brain’s neuron system. The emergence of artificial intelligence and increasing adoption of the artificial neural network in the healthcare sector are the major drivers for the global artificial neural market. Factors such as the increasing healthcare expenditure, growing number of hospitalizations, and increasing prevalence of chronic diseases contribute to the growth of the market. Moreover, artificial neural networks provide significant benefits in medical research which is expected to fuel the market growth during the forecast period. Furthermore, owing to the growing adoption of artificial neuron network, many companies are engaged in developing artificial neuron network-based software. For instance, MAQ software by Microsoft implements an Artificial Neural Network (ANN) to learn from the historical data and predict the future values.

Despite the drivers, slow digitization across emerging economies and reluctance among healthcare professionals to adopt artificial intelligence-based technologies are likely to hamper the growth of the market during the assessment period.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/6287

Segmentation

The global artificial neural network market has been segmented into type, component, and application.

The market, on the basis of type, has been segmented into feedback artificial neural network, feedforward artificial neural network, and others.

The market, by component, has been segmented into software, services, and platform.

The global artificial neural network market, by application, has been segmented into clinical diagnosis and prognostics, image analysis and interpretation, bioelectric signal analysis and interpretation, drug development, and others.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The artificial neural network market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European artificial neural network market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The artificial neural network market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The artificial neural network market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players

Neural Technologies Limited, SwiftKey, Starmind International AG, Afiniti, Ward Systems Group, Inc., SAP SE, NeuroDimension, Inc., Alyuda Research, LLC, Google Inc., Neuralware, Qualcomm Technologies, Inc., Intel Corporation, Microsoft Corporation, IBM Corporation, and Oracle Corporation are some of the key players in the global artificial neural network market.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the global artificial neural network market owing to a well-developed healthcare sector, due to the presence of a large number of enterprises in the development of neural network technologies, and high adoption advanced technology in the healthcare sector. According to the Centers for Disease Control and Prevention, in 2015, the total national health expenditure was USD 3.2 trillion.

Europe is expected to hold the second largest position in the global artificial neural network market. The market growth in this region is attributed to the growing adoption of artificial intelligence among healthcare providers and increasing healthcare expenditure coupled with the rising prevalence of chronic diseases.

Read Comprehensive Overview of Report @ https://www.marketresearchfuture.com/reports/artificial-neural-network-market-6287

The Asia-Pacific region is expected to exhibit the fastest growth throughout the forecast period owing to the accelerated economic growth of countries in the region and the growing need to control the increasing healthcare costs. These factors are also responsible for the emerging trend towards the digitization of patient records among healthcare organizations in this region.

The Middle East & Africa has the least share of the global artificial neural network market. However, this region is expected to have a potential growth opportunity for the artificial neural network market during the forecast period. The key factors driving the growth rate in this region include increasing technological implementations and rising healthcare investments.